These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32475136)

  • 21. Alexithymia in people with subjective cognitive decline, mild cognitive impairment, and mild Alzheimer's disease.
    Yuruyen M; Akcan FE; Batun GC; Gultekin G; Toprak M; Yavuzer H; Emul M
    Aging Clin Exp Res; 2017 Dec; 29(6):1105-1111. PubMed ID: 28110464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between benzodiazepine use and development of dementia.
    Aldaz P; Garjón J; Beitia G; Beltrán I; Librero J; Ibáñez B; Arroyo P; Ariz MJ
    Med Clin (Barc); 2021 Feb; 156(3):107-111. PubMed ID: 32434656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients.
    Begic E; Hadzidedic S; Kulaglic A; Ramic-Brkic B; Begic Z; Causevic M
    PLoS One; 2019; 14(2):e0212261. PubMed ID: 30763368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.
    Pillai JA; Bermel R; Bonner-Jackson A; Rae-Grant A; Fernandez H; Bena J; Jones SE; Ehlers JP; Leverenz JB
    Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):430-6. PubMed ID: 26888864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.
    Rozzini L; Lanfranchi F; Pilotto A; Catalani S; Gilberti ME; Paganelli M; Apostoli P; Padovani A
    J Alzheimers Dis; 2018; 61(3):907-912. PubMed ID: 29332043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition.
    Zhang Y; Zhou XH; Meranus DH; Wang L; Kukull WA
    Alzheimer Dis Assoc Disord; 2016; 30(2):113-7. PubMed ID: 26067923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moderating risk of Alzheimer's disease through the use of anxiolytic agents.
    Burke SL; O'Driscoll J; Alcide A; Li T
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1312-1321. PubMed ID: 27805724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of nurses in addressing modifiable risk factors for early Alzheimer's disease and mild cognitive impairment.
    Hope K
    Br J Nurs; 2020 Apr; 29(8):460-469. PubMed ID: 32324452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    Drug Saf; 2015 Oct; 38(10):909-19. PubMed ID: 26123874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes.
    Ulstein I; Bøhmer T
    J Alzheimers Dis; 2017; 55(2):717-725. PubMed ID: 27716664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of emotional decoding abilities in patients with amnestic mild cognitive impairment, very mild and mild Alzheimer's disease.
    Klimkowicz-Mrowiec A; Krzywoszanski L; Spisak K; Donohue BE; Szczudlik A; Slowik A
    Curr Alzheimer Res; 2014 Feb; 11(2):200-5. PubMed ID: 24359502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment.
    Wilcockson TDW; Mardanbegi D; Xia B; Taylor S; Sawyer P; Gellersen HW; Leroi I; Killick R; Crawford TJ
    Aging (Albany NY); 2019 Aug; 11(15):5389-5398. PubMed ID: 31375642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
    Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
    Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
    J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medications to modify at-home behavior of Alzheimer's patients.
    Maletta GJ
    Geriatrics; 1985 Dec; 40(12):31-6, 39-40, 42. PubMed ID: 2866147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.